Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-074410
Filing Date
2011-08-08
Accepted
2011-08-08 16:01:23
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f59706e10vq.htm 10-Q 458207
2 EX-3.1 f59706exv3w1.htm EX-3.1 22666
3 EX-3.2 f59706exv3w2.htm EX-3.2 10201
4 EX-31.1 f59706exv31w1.htm EX-31.1 5912
5 EX-31.2 f59706exv31w2.htm EX-31.2 6120
6 EX-32.1 f59706exv32w1.htm EX-32.1 3919
12 GRAPHIC f59706d8391600.gif GRAPHIC 12063
  Complete submission text file 0000950123-11-074410.txt   1920825

Data Files

Seq Description Document Type Size
7 EX-101 INSTANCE DOCUMENT alxa-20110630.xml EX-101.INS 222070
8 EX-101 SCHEMA DOCUMENT alxa-20110630.xsd EX-101.SCH 12991
9 EX-101 CALCULATION LINKBASE DOCUMENT alxa-20110630_cal.xml EX-101.CAL 38590
10 EX-101 LABELS LINKBASE DOCUMENT alxa-20110630_lab.xml EX-101.LAB 117117
11 EX-101 PRESENTATION LINKBASE DOCUMENT alxa-20110630_pre.xml EX-101.PRE 67881
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 111017117
SIC: 2834 Pharmaceutical Preparations